PERORA
Heidelberg
About PERORA
Leading in metabolic health. We produce and market REDIA, the first nutritional supplement with a health claim for postprandial lowering of blood sugar. Patents granted in EU, US and many other countries. Clinically validated in diabetes type 2 patients. Available in Germany through www.redia.health, and online pharmacies. We aim to build a subscription business for the self-management of chronic age-related metabolic health in Europe, and license our product internationally.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2017)
- Website: perora.com
- Phone: 49 6221 4344730
Industries & Categories
Advanced Materials, Health Care, Snack Food
Social Profiles
Canonical: https://fsome.com/organization/perora-2630393 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.